Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (9447)	3/30/1999 11:01:00 AM
From: aknahow	Respond to of 17367

Intriguing!! Message 8600982 This in no way means XOMA is involved, but the fact remains they are more likely to be involved than 80% of the other biotech companies that could not be considered to have protein therapies. XOMA has been too busy to tie its' shoes lately. Lawyers can't find time to approve stuff for web that does not say diddly squat. Something may have higher priority. Roumor Mill site has been mentioning Bayer/XOMA for some time but in terms of a merger. I really doubt the merger stuff. I would not mind seeing a partnership with Bayer if the terms were right.

To: Bluegreen who wrote (9447)	3/30/1999 11:37:00 AM
From: aknahow	Respond to of 17367

Protein therapeutics covers a large area, so no one should think XOMA does more than fall into that are and is located close to Bayer in Berkley. R 6 THERAPEUTIC PROTEINS 6.1 Introduction to recombinant communicator proteins 6.2 Cytokines 6.2.1 Granulocyte CSF 6.2.2 Granulocyte-macrophage CSF 6.2.3 Macrophage CSF 6.2.4 Interleukins 6.2.5 Interferons 6.2.6 Chemotactic factors 6.2.7 Other tissue repairing agents 6.3 Other growth factors 6.3.1 Transforming growth factors 6.3.2 Tumour necrosis factor 6.3.3 Stem cell factor 6.3.4 Mast cell growth factor 6.4 Structural proteins 6.4.1 Blocking agents 6.4.2 Surfactants (for lung cells) 6.5 Blood products 6.5.1 alpha-1-antitrypsin 6.5.2 Factor VIII 6.5.3 Thrombolytics/fibrinolytics 6.5.4 Superoxide dismutase 6.5.5 Erythropoietin 6.5.6 Blood substitutes 6.6 Metabolic products 6.6.1 Insulin 6.6.2 Pro-insulin 6.6.3 Human growth hormone 6.6.4 Atrial peptide 6.7 Summary